Launch Of KIHT A Major Boost Towards
Making India A Global Manufacturing Hub For Medical Devices: AiMeD
The recently launched Kalam Institute of Health Technology (KIHT),
India’s first institute dedicated to medical technology located at Andhra
Pradesh MedTech Zone (AMTZ), Visakhapatnam, will prove to be a major boost
towards making India a global manufacturing hub for medical devices, according
to the Association of Indian Medical Device Industry (AiMeD), an association of
medical devices manufacturers in the country.
Named after India’s 11th President Dr APJ Abdul Kalam, KIHT
has been set up with the aim to identify critical gaps in medical technology and
suggest the government to do focused spending on such areas and help bridge the
gap between academic research and industrial market access, by auctioning of
patents and prototypes available with government funded academic research
institutions.
Rajiv Nath, Forum Coordinator, AiMED said “We are extremely
happy that the 1st Governing Body meet of KIHT is a major step towards making
India a global manufacturing hub for medical device sector and to build a robust
system for innovation in the medical devices sector in the country.”
AiMeD is also on KIHT’s Governing Board and will spearhead
and coordinate the indigenous development of medical devices. In the first
Governing Body meeting held in Delhi recently, KIHT has been identified as nodal
point for medical technology program support cell for national biopharma
mission; KIHT has been accepted as the facilitator for DBT/BIRAC funded
innovations for helping them with certifications; and there was an approval
accorded for technology e-auction.
KIHT is being guided by stalwarts of the scientific community
like Dr. R. Chidambram, Principal Scientific Advisor to Government of India as
president and the Governing Body members include: Prof. Vijay Raghavan -
Secretary Department of Biotechnology (DBT) as chairperson; Dr Poonam
Malakondaiah - Principal Secretary (HM&FW), Govt. of Andhra Pradesh; Dr.Renu
Swarup - Senior Advisor, DBT & MD, BIRAC; Rajiv Agarwal - Joint Secretary,
Department of Industrial Policy & Promotion (DIPP), Govt. of India; Dr. Swati
Basu - Scientific Secretary, Office of Principal Scientific Adviser to Govt. of
India; Rajiv Nath - Forum Coordinator, AIMED; Prof. B. Ravi - Institute Chair
Professor, IIT Bombay, Mumbai; Prof. Balaram Bhargava - Executive Director,
School of International Bio-Design, AIIMS, New Delhi and Dr. Jitendar Sharma -
Managing Director & CEO, AMTZ, Visakhapatnam as Executive Director.
(Ref : http://pharmabiz.com NewsDetails.aspx?aid=105451&sid=1)
India Aims To Ease Import Process For
Medical Devices
Medical device and IVD imports to India should not be held up
at ports because of “slight confusions” over product names, pending applications
during mergers and acquisitions, or shelflife issues if the importers have valid
registration certificates and import licenses, according to the Central Drugs
Standard Control Organization. CDSCO issued notice to port offices in response
to complaints that products were being inappropriately withheld for those
reasons.
U.S. device makers, meanwhile, continue to push back against
India’s new price controls on certain devices that resulted in sharp decreases
in their average prices, and say some may pull their products from the Indian
market.
(Ref :
https://www.fdanews.com/articles/184376-india-aims-to-easeimport
-process-for-medical-devices)
|